Osmosis
Medical education platform for students and healthcare professionals
Company profile
Company profile
Osmosis is a medical education platform that delivers comprehensive learning resources for healthcare students and professionals. The company focuses on providing video-based educational content, study materials, and clinical training tools designed to support medical education across various healthcare disciplines. Osmosis aims to make medical learning more accessible and effective through digital platforms that combine visual learning with evidence-based content. The platform serves medical students, nursing students, and healthcare professionals seeking to enhance their clinical knowledge and skills through structured, engaging educational materials.
Company description Osmosis official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Medical education platform for students and healthcare professionals
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
PeerJ · Jan 1, 2026
Characterisation and Phylogenetic Analysis of the Complete Plastid Genome of Physalis minima L. from Malaysia.Tropical life sciences research · Oct 1, 2025
Impacts of Black Soldier Fly (Hermetia illucens) Larval Meal on Intestinal Histopathology and Microbiome Responses in Hybrid Grouper (Epinephelus fuscoguttatus ♀ × E. lanceolatus ♂): A Comprehensive Analysis.Animals : an open access journal from MDPI · Dec 12, 2024
First-Year Medical Student Experiences Adjusting to the Immediate Aftermath of COVID-19.Medical science educator · Apr 1, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development.Bioengineering & translational medicine · Jan 1, 2021
Correction: Sustainable process for the preparation of potassium sulfate by electrodialysis and its concentration and purification by a nanofiltration process.RSC advances · Nov 9, 2020
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Osmosis's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI, virtual reality, augmented reality, or immersive technologies to provide medical education, surgical training, clinical skills development, or continuing medical education for healthcare professionals. Focuses on training and skills development rather than direct patient care delivery.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.